Precision Oncology: <b>ACT Oncology</b> Appoints New Chief Medical Officer

FLEMINGTON, NJ--(Marketwired - October 23, 2015) - ACT Oncology (ACT), an oncology specialist Clinical Research Organization (CRO), is pleased to announce the appointment of Gerald Messerschmidt, M.D., FACP, as Chief Medical Officer (CMO). Formerly a consultant for the company, Dr. Messerschmidt will provide medical and safety leadership in addition to lending his expertise...